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Abstract
Background
Bipolar disorder is a significant cause of morbidity and mortality. Although existing treat-
ments are effective, there is often a substantial delay before diagnosis and treatment initia-
tion. We sought to investigate factors associated with the delay before diagnosis of bipolar
disorder and the onset of treatment in secondary mental healthcare.
Method
Retrospective cohort study using anonymised electronic mental health record data from the
South London and Maudsley NHS Foundation Trust (SLaM) Biomedical Research Centre
(BRC) Case Register on 1364 adults diagnosed with bipolar disorder between 2007 and
2012. The following predictor variables were analysed in a multivariable Cox regression
analysis: age, gender, ethnicity, compulsory admission to hospital under the UK Mental
Health Act, marital status and other diagnoses prior to bipolar disorder. The outcomes were
time to recorded diagnosis from first presentation to specialist mental health services (the
diagnostic delay), and time to the start of appropriate therapy (treatment delay).
Results
The median diagnostic delay was 62 days (interquartile range: 17–243) and median treat-
ment delay was 31 days (4–122). Compulsory hospital admission was associated with a
significant reduction in both diagnostic delay (hazard ratio 2.58, 95% CI 2.18–3.06) and
treatment delay (4.40, 3.63–5.62). Prior diagnoses of other psychiatric disorders were asso-
ciated with increased diagnostic delay, particularly alcohol (0.48, 0.33–0.41) and substance
misuse disorders (0.44, 0.31–0.61). Prior diagnosis of schizophrenia and psychotic depres-
sion were associated with reduced treatment delay.
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Conclusions
Some individuals experience a significant delay in diagnosis and treatment of bipolar disor-
der after initiation of specialist mental healthcare, particularly those who have prior diagno-
ses of alcohol and substance misuse disorders. These findings highlight a need for further
study on strategies to better identify underlying symptoms and offer appropriate treatment
sooner in order to facilitate improved clinical outcomes, such as developing specialist early
intervention services to identify and treat people with bipolar disorder.
Introduction
Bipolar disorder is a major global health problem, associated with increased mortality[1,2],
substantial disability[3], and major societal economic impact[4]. However people with bipolar
disorder often experience delays of several years before receiving a diagnosis and appropriate
treatment. Retrospective studies from USA and Australia have found that people with bipolar
disorder report delays of more than five years, often more than ten years, between the onset of
illness and diagnosis[5,6]. Moreover, studies from specialist centres typically find there to have
also been substantial delays of many years before initiation of appropriate medication[7–10].
Delayed diagnosis and treatment of bipolar disorder are associated with poorer long term
outcomes[8,10,11], and repeated episodes of bipolar disorder are associated with increased vul-
nerability to relapse[12] and deteriorations in cognitive function[13]. Furthermore, the failure
to correctly recognise underlying bipolar disorder may lead to an individual receiving inappro-
priate treatment such as antidepressant monotherapy which may be associated with increased
risk of developing mania[14,15].
One of the barriers to the prompt recognition and management of this group may be a fail-
ure to recognise symptoms indicative of underlying bipolar disorder[16], and the attribution of
these to another mental illness[17] or comorbid substance misuse[18]. Furthermore, the nature
of psychopathology experienced by an individual with bipolar disorder can vary significantly
over the course of illness[19]. In the early stages, the pattern of symptoms may not be well
characterised by criterion-based ICD/DSM diagnostic classification potentially leading to a
delay in receiving appropriate treatment[20].
An improved understanding of factors associated with delay to diagnosis and delay to treat-
ment would inform the development of strategies to reduce them. In the present study, we ana-
lysed clinical data from individuals with bipolar disorder in a large geographically-defined
community in order to estimate the delay to diagnosis and initiation of appropriate treatment
after presentation to mental health services. Our first hypothesis was that even when they are
assessed by mental health teams, there are still significant delays before patients with bipolar
disorder receive a diagnosis and appropriate treatment. We also investigated the factors associ-
ated with delays to diagnosis and treatment, and tested the hypothesis that these delays would
be longer in patients who had previously been diagnosed with other mental illnesses or comor-
bid alcohol and substance misuse.
Methods
Participants
Data were obtained from the South London and Maudsley NHS Foundation Trust (SLaM) Bio-
medical Research Centre Case Register. Under the National Health Service (NHS) system in
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the UK, there is universal state provision of healthcare with Mental Health Trusts providing
specialist mental healthcare to people living in defined geographic catchment areas[21]. In
order to obtain specialist mental healthcare, patients typically consult their local general practi-
tioner (a provider of primary healthcare) who may then initiate a referral to the respective spe-
cialist mental healthcare service. Alternatively, patients may be referred to specialist mental
healthcare services after presenting to emergency departments and some services accept direct
patient referrals. Initial assessments may be performed by a trainee or consultant psychiatrist
or other mental healthcare professional[21]. The South London and Maudsley NHS Founda-
tion Trust (SLaM) is one of Europe’s largest provider of secondary mental healthcare, serving
four boroughs in southeast London (urban and suburban areas) with a geographic catchment
of approximately 1.2 million residents and provision of all aspects of secondary mental health-
care to all age groups including inpatient, community, general hospital liaison and forensic ser-
vices. Fully electronic clinical records have been implemented in all SLaM services since 2007,
and an electronic case register (the SLaM BRC Case Register) has been developed by the SLaM
BRC for Mental Health rendering anonymised electronic clinic records data available for re-
search on over 250,000 people receiving care from SLaM[22], with a robust patient-led gover-
nance framework. The SLaM Case Register has been approved as an anonymised data resource
for secondary analyses by Oxfordshire Research Ethics Committee C (08/H0606/71+5) and
governance is provided for all projects by a patient-led oversight committee in the Biomedical
Research Centre, South London and Maudsley NHS Trust[23].
Using the SLaM BRC Case Register, a cohort of 1364 individuals meeting the following cri-
teria were identified:
i. First presentation to SLaM between 1st January 2007 and 31st December 2012 to an inpatient
or community mental health service.
ii. Age between 16 and 65 years at first presentation.
iii. Subsequent diagnosis of mania or bipolar affective disorder before 31st December 2013 de-
fined according to ICD-10 diagnostic categories F30.x and F31.x.
Of these, 344 (25.2%) presented initially to inpatient services and the remainder presented
to community services.
In order to ensure that participants included in the analysis had a stable diagnosis of bipolar
disorder, only participants whose mania or bipolar disorder diagnosis was confirmed at least
once within one year of initial diagnosis were included. The time period of 2007 to 2012 was
chosen as 2007 was the first full year in which electronic health records were implemented in
all SLaM services (thereby ensuring a representative clinical sample of individuals receiving
specialist mental healthcare) and to ensure that all individuals in the study had at least one year
of follow-up data available.
Source of clinical data
Data were extracted from the BRC Case Register using the Clinical Record Interactive Search
(CRIS) application[22]. The CRIS application is a bespoke software package which permits fo-
cussed searching of anonymised electronic health records in the SLaM BRC Case Register and
has contributed to a wide range of epidemiological studies of mental disorder outcomes
[1,24,25]. The records include structured fields for demographic information and clinical ques-
tionnaires as well as unstructured free text to record history, mental state examination, diag-
nostic formulation and management plan. The clinical data are those recorded
contemporaneously by mental health professionals during routine clinical care and included
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correspondence between healthcare professionals such as clinic letters and discharge summa-
ries. In order to maximise ascertainment of diagnosis and medication, data on these variables
were obtained from unstructured free text clinical entries (as well as structured text fields)
using natural language processing (NLP)[26]. All other variables were ascertained from
structured fields.
Predictor variables
The CRIS application was used to extract the following predictor variables from the dataset:
whether admitted to hospital compulsorily under the UK Mental Health Act (MHA) within 2
weeks of first presentation to SLaM, and diagnoses of schizophrenia and related disorders
(ICD-10 F2x), psychotic depression (ICD-10 F32.3/F33.3), unipolar depression without psy-
chotic symptoms (ICD-10 F32/33 excluding F3x.3), anxiety disorder (ICD-10 F4x), personality
disorder (ICD-10 F60/F61), alcohol misuse/dependence (ICD-10 F10.x) or illicit drug misuse/
dependence (ICD-10 F11-19.x) recorded prior to the date of first bipolar disorder diagnosis.
The following variables were extracted as covariates for multivariable analyses: age, gender,
ethnicity and marital status. All covariate data obtained were those closest to the time of first
referral to SLaM.
Outcome variables
The primary outcome variable was time to diagnosis of bipolar disorder (in days) measured
from the date of first presentation to SLaM. We considered this time to represent the delay to
diagnosis of bipolar disorder while receiving specialist mental healthcare. The secondary out-
come variable was time to first prescription of appropriate treatment (in days) measured from
the date of first presentation to SLaM. We considered this time to represent the delay to initiat-
ing treatment. Following previous work in this area[9] we defined appropriate pharmacological
treatment with reference to the British Association of Psychopharmacology guidelines[27] as
initiation of any of second generation antipsychotic, lithium, valproate, carbamazepine and
lamotrigine[9].
Statistical analysis
STATA (version 12) software was used[28]. Descriptive statistics for predictor and outcome
variables were obtained as means and standard deviations for continuous variables (diagnostic
delay and treatment delay) and as frequencies and percentages for all other variables. Associa-
tions between predictor/covariate variables and diagnostic delay/treatment delay were investi-
gated using Kaplan-Meier survival analysis and multivariable Cox regression. Proportionality
of hazards was tested on Schoenfeld residuals of diagnostic delay and treatment delay using the
phtest command in STATA[28]. The hazard ratios in Cox regression analyses represent the
probability of bipolar disorder diagnosis or initiation of treatment occurring during the period
of follow-up. Therefore, a hazard ratio greater than 1.0 indicates an association of a predictor
variable with reduced time to diagnosis or treatment compared to the reference category. Ref-
erence categories for Cox regression analysis were defined as those of greatest prevalence. In
order to adjust for comorbidity between prior diagnoses, all prior diagnoses were entered as in-
dividual binary variables in the Cox regression analysis rather than analysing these as a single
categorical variable. Bonferroni correction of confidence intervals and p values was performed
to mitigate the possibility of a type 1 statistical error for categorical variables with more than
one category. By virtue of the study inclusion criteria, all participants were diagnosed with bi-
polar disorder and so no censoring was required in the survival analysis of diagnostic delay. A
further analysis of diagnostic delay using multiple linear regression was also performed as a
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sensitivity analysis. For analysis of treatment delay, the outcome of starting appropriate treat-
ment was censored at 31st December 2013. To investigate the impact of missing covariate data,
the main analyses included missing data as a separate category and further sensitivity analyses
were performed including only participants with full covariate data.
Results
Diagnostic delay
The median delay to diagnosis of bipolar disorder was 62 days (IQR 17–243). Kaplan-Meier
analysis (Fig 1) illustrates the distribution of diagnostic delay over time. Table 1 shows the
breakdown of diagnostic delay according to demographic characteristics and diagnoses re-
corded prior to bipolar disorder. There were no significant differences in diagnostic delay de-
pending on age, gender, ethnicity or marital status. Prior diagnoses of other psychiatric
disorders were associated with increased diagnostic delay compared to people without these
prior diagnoses. In particular, prior diagnoses of alcohol or substance misuse disorders were
Fig 1. Kaplan-Meier plot of diagnostic delay.
doi:10.1371/journal.pone.0126530.g001
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Table 1. Factors associated with bipolar disorder diagnostic delay (n = 1364).
Factor Group Number in
sample
Percentage Median
diagnostic delay
in days (IQR)
*Adjusted
hazard ratio
95% conﬁdence
interval, p value
Bonferroni corrected
95% conﬁdence
interval, p value
Age (years) 16–25 354 26.0% 75 (21–306) 0.93 0.80–1.08,
p = 0.33
0.77–1.12, p = 1.0
26–35 442 32.4% 58 (15–201) Reference
36–45 314 23.0% 64 (21–262) 0.93 0.80–1.08,
p = 0.36
0.77–1.13, p = 1.0
46–55 158 11.6% 49 (12–164) 1.00 0.83–1.20,
p = 0.99
0.79–1.27, p = 1.0
56–65 96 7.0% 48 (13–360) 0.95 0.75–1.19,
p = 0.64
0.71–1.27, p = 1.0
Gender Female 796 58.4% 62 (16–240) Reference
Male 644 47.2% 63 (21–256) 1.01 0.90–1.13,
p = 0.88
0.90–1.13, p = 0.88
Ethnicity White 837 61.4% 66 (18–262) Reference
Asian 71 5.2% 63 (14–300) 0.75 0.58–0.99,
p = 0.03
0.54–1.05, p = 0.13
Black 239 17.5% 54 (12–301) 1.02 0.87–1.19,
p = 0.84
0.83–1.25, p = 1.0
Other 170 12.5% 56 (22–169) 1.07 0.90–1.26,
p = 0.46
0.86–1.32, p = 1.0
Ethnicity not recorded 47 3.4% 54 (19–148) 0.83 0.61–1.12,
p = 0.22
0.56–1.22, p = 0.87
Marital
status
Married/Cohabiting 318 23.3% 49 (14–211) 1.10 0.96–1.26,
p = 0.19
0.92–1.31, p = 0.76
Divorced/Separated 121 8.9% 79 (22–415) 0.94 0.76–1.15,
p = 0.53
0.72–1.22, p = 1.0
Single 824 60.4% 67 (19–270) Reference
Widowed 12 0.9% 49 (12–140) 1.08 0.60–1.96,
p = 0.79
0.51–2.30, p = 1.0
Marital status not
recorded
89 6.5% 35 (9–101) 1.45 1.16–1.83,
p = 0.001
1.09–1.95, p = 0.005
UK Mental
Health Act
Compulsory admission
within 2 weeks of ﬁrst
presentation
232 17.0% 18 (6–70) 2.58 2.18–3.06,
p<0.001
2.18–3.06, p<0.001
Prior
Diagnoses
Schizophrenia or related
disorders
215 15.8% 212 (48–670) 0.41 0.34–0.48,
p<0.001
0.34–0.48, p<0.001
Psychotic depression 37 2.7% 370 (93–929) 0.71 0.50–1.00,
p = 0.05
0.50–1.00, p = 0.05
Unipolar depression
without psychotic
symptoms
138 10.1% 409 (123–1051) 0.41 0.34–0.49,
p<0.001
0.34–0.49, p<0.001
Anxiety disorder 82 6.0% 442 (158–901) 0.52 0.41–0.65,
p<0.001
0.41–0.65, p<0.001
Personality disorder 54 4.0% 504 (169–1044) 0.59 0.45–0.79,
p<0.001
0.45–0.79, p<0.001
Alcohol misuse or
dependence
27 2.0% 705 (356–1341) 0.48 0.33–0.71,
p<0.001
0.33–0.71, p<0.001
Illicit drug misuse or
dependence
36 2.6% 742 (320–1142) 0.44 0.31–0.61,
p<0.001
0.31–0.61, p<0.001
*Model adjusted for all factors listed in this table
doi:10.1371/journal.pone.0126530.t001
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associated with substantially longer median delays to diagnosis. Compulsory admission under
the UK Mental Health Act was associated with decreased diagnostic delay. These findings were
corroborated on multivariable Cox Regression analysis. Multiple linear regression yielded com-
parable results (Table 2). A test of proportionality of hazards (Table 3) revealed a skewed distri-
bution of diagnostic delay for compulsory admission, and prior diagnoses of schizophrenia
and related disorders, unipolar depression without psychotic symptoms, anxiety disorders and
illicit drug misuse or dependence. Although people with no recorded marital status were found
to have shorter diagnostic delay, a sensitivity analysis including only those with full covariate
data (Table 4) did not result in meaningful changes to the main findings.
Treatment delay
Of the 1364 individuals included in this study, 1206 received appropriate treatment prior to
31st December 2013 (where data were censored). 117 individuals had a treatment delay of zero
days and were not included in the multivariable Cox regression analysis resulting in 1247 par-
ticipants included in this analysis. The median treatment delay was 31 days (IQR 4–122). 688
individuals (57.0%) were found to have a shorter treatment delay than diagnostic delay.
Kaplan-Meier analysis (Fig 2) illustrates the distribution of treatment delay over time. Table 5
shows the breakdown of treatment delay according to demographic characteristics and diagno-
ses recorded prior to bipolar disorder. There were no significant differences in treatment delay
depending on age, gender, ethnicity or marital status. In contrast to diagnostic delay, prior di-
agnoses of schizophrenia (and related disorders) and psychotic depression were associated
with a reduction in median treatment delay. The greatest median treatment delay was seen
among people with prior alcohol misuse/dependence. Compulsory admission under the UK
Mental Health Act was associated with short treatment delay. A test of proportionality of haz-
ards (Table 6) revealed a skewed distribution of treatment delay for compulsory admission and
prior diagnoses of unipolar depression without psychotic symptoms and anxiety disorder. A
sensitivity analysis including only those with full covariate data (Table 7) did not result in
meaningful changes to these results.
Variability in delays between patients
For both the delay before diagnosis, and the delay before treatment, the median and mean esti-
mates do not convey the very large range in the length of these delays across the sample. In
some patients, diagnosis and treatment were made within one day of presentation, but in oth-
ers the delays extended for over five years (maximum diagnostic delay: 2110 days; maximum
treatment delay: 2053 days.
Discussion
Using a large electronic case register, we investigated the delay to diagnosis of bipolar disorder
from initiation of specialist mental healthcare. The median delay to diagnosis from the point of
receiving specialist mental healthcare was 62 days but varied widely (interquartile range 17–
243 days). It is important to recognise that this figure does not correspond to the delay between
the patient first experiencing symptoms, and diagnosis (which would be much longer), but the
time between presentation to mental health services and diagnosis. Previous studies have indi-
cated that delays to diagnosis from first experiencing symptoms of around 10 years[5–7] sug-
gesting that there is a substantial delay from first experiencing symptoms to receiving mental
healthcare. These studies obtained data from questionnaires given to patients with an estab-
lished diagnosis of bipolar disorder. While they were able to elicit delays from first symptoms
to bipolar disorder diagnosis, their retrospective designs are limited by the possibility of recall
Diagnostic and Treatment Delay in Bipolar Disorder
PLOS ONE | DOI:10.1371/journal.pone.0126530 May 20, 2015 7 / 17
Table 2. Factors associated with bipolar disorder diagnostic delay (n = 1364) analysed usingmultiple linear regression.
Factor Group Number in
sample
Percentage Median
diagnostic delay
in days (IQR)
*Adjusted B
coefﬁcient
(days)
95% conﬁdence
interval, p value
Bonferroni corrected
95% conﬁdence
interval, p value
Age (years) 16–25 354 26.0% 75 (21–306) 6.4 -41.1, 53.9,
p = 0.79
-54.1, 66.9, p = 1.0
26–35 442 32.4% 58 (15–201) Reference
36–45 314 23.0% 64 (21–262) 2.4 -46.5, 51.2,
p = 0.92
-59.9, 64.6, p = 1.0
46–55 158 11.6% 49 (12–164) -24.3 -85.7, 37.1,
p = 0.44
-102.6, 54.0, p = 1.0
56–65 96 7.0% 48 (13–360) 28.2 -47.2, 103.6,
p = 0.46
-67.9, 124.4, p = 1.0
Gender Female 796 58.4% 62 (16–240) Reference
Male 644 47.2% 63 (21–256) -9.4 -45.3, 26.5,
p = 0.61
-45.3, 26.5, p = 0.61
Ethnicity White 837 61.4% 66 (18–262) Reference
Asian 71 5.2% 63 (14–300) 51.4 -29.8, 132.7,
p = 0.21
-52.1, 155.0, p = 0.86
Black 239 17.5% 54 (12–301) 23.4 -26.8, 73.6,
p = 0.36
-40.6, 87.5, p = 1.0
Other 170 12.5% 56 (22–169) -6.3 -60.9, 48.4,
p = 0.82
-75.9, 63.4, p = 1.0
Ethnicity not recorded 47 3.4% 54 (19–148) 49.1 -49.8, 147.9,
p = 0.33
-77.0, 175.1, p = 1.0
Marital
status
Married/Cohabiting 318 23.3% 49 (14–211) -7.9 -53.6, 37.8,
p = 0.73
-66.2, 50.3, p = 1.0
Divorced/Separated 121 8.9% 79 (22–415) 23.3 -43.4, 90.0,
p = 0.49
-61.7, 108.3, p = 1.0
Single 824 60.4% 67 (19–270) Reference
Widowed 12 0.9% 49 (12–140) -1.4 -193.7, 191.0,
p = 0.99
-246.6, 243.9, p = 1.0
Marital status not
recorded
89 6.5% 35 (9–101) -80.4 -154.8, -6.1,
p = 0.03
-175.2, 14.4, p = 0.14
UK Mental
Health Act
Compulsory admission
within 2 weeks of ﬁrst
presentation
232 17.0% 18 (6–70) -144.3 -194.4, -94.2,
p<0.001
-194.4, -94.2, p<0.001
Prior
Diagnoses
Schizophrenia or related
disorders
215 15.8% 212 (48–670) 214.8 163.6, 266.0,
p<0.001
163.6, 266.0, p<0.001
Psychotic depression 37 2.7% 370 (93–929) 129.7 17.4, 242.1,
p = 0.02
17.4, 242.1, p = 0.02
Unipolar depression
without psychotic
symptoms
138 10.1% 409 (123–1051) 352.6 292.1, 413.0,
p<0.001
292.1, 413.0, p<0.001
Anxiety disorder 82 6.0% 442 (158–901) 235.6 160.1, 311.2,
p<0.001
160.1, 311.2, p<0.001
Personality disorder 54 4.0% 504 (169–1044) 242.6 148.3, 336.9,
p<0.001
148.3, 336.9, p<0.001
Alcohol misuse or
dependence
27 2.0% 705 (356–1341) 461.8 334.5, 589.1,
p<0.001
334.5, 589.1, p<0.001
Illicit drug misuse or
dependence
36 2.6% 742 (320–1142) 363.0 249.9, 476.1,
p<0.001
249.9, 476.1, p<0.001
*Model adjusted for all factors listed in this table
doi:10.1371/journal.pone.0126530.t002
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and information bias. It was not possible to obtain data from first symptoms to diagnosis in
our study but our findings are strengthened by the use of prospectively recorded clinical data.
Our study included a maximum follow-up period of seven years (1st January 2007 to 31st
December 2013). It is therefore possible that a longer follow-up period would have identified
more people with greater diagnostic delay. However, given that the 75th percentile for diagnos-
tic delay was reached within one year follow-up, it is unlikely that a significant proportion of
people had a delay to diagnosis from first presentation to mental health services extending be-
yond the period of this study. Although, based on previous studies, it is likely that there was a
substantial additional delay from first experiencing symptoms to receiving specialist
mental healthcare.
In our study, the median delay to receiving appropriate treatment for bipolar disorder was
31 days (interquartile range 4–122). The fact that the treatment delay was shorter than diagnos-
tic delay in the majority of participants may reflect the initiation of treatment by clinicians
prior to recording a formal diagnosis of bipolar disorder in electronic health records or in cor-
respondence to other healthcare professionals. The median treatment delay in our study com-
pares with a mean delay of 4.4 years following hospital admission in a study reported by
Drancourt et al[9]. It may be that differences between our study and Drancourt et al reflect var-
iations in the distribution of mental healthcare between primary and secondary services in dif-
ferent healthcare settings[29]. It is possible that in our study a substantial delay has already
occurred from the time of first seeking help in primary care services to being referred to
Table 3. Test of proportionality of hazards on Schoenfeld residuals for diagnostic delay.
Factor Group Rho χ2 P value
Age (years) 16–25 0.04 2.6 0.11
26–35 Reference
36–45 0.04 2.4 0.12
46–55 0.01 0.1 0.77
56–65 -0.03 1.5 0.22
Gender Female Reference
Male 0.03 0.9 0.35
Ethnicity White Reference
Asian -0.04 2.6 0.11
Black 0.01 0.05 0.83
Other 0.06 5.8 0.02
Ethnicity not recorded -0.02 0.5 0.48
Marital status Married/Cohabiting 0.01 0.3 0.59
Divorced/Separated 0.00 0.0 0.89
Single Reference
Widowed 0.01 0.1 0.71
Marital status not recorded 0.03 1.1 0.29
UK Mental Health Act Compulsory admission within 2 weeks of ﬁrst presentation -0.14 31.4 <0.001
Prior Diagnoses Schizophrenia or related disorders 0.14 28.6 <0.001
Psychotic depression 0.05 2.9 0.09
Unipolar depression without psychotic symptoms 0.12 17.9 <0.001
Anxiety disorder 0.12 20.9 <0.001
Personality disorder 0.06 4.0 0.05
Alcohol misuse or dependence 0.04 1.6 0.20
Illicit drug misuse or dependence 0.08 8.7 0.003
doi:10.1371/journal.pone.0126530.t003
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secondary mental healthcare services (resulting in a relative reduction in delay to diagnosis
after presenting to secondary mental healthcare services) and that the threshold for initiating
such a referral varies between different healthcare settings. Further research investigating
Table 4. Factors associated with bipolar disorder diagnostic delay only including participants with complete covariate data (n = 1244).
Factor Group Number in
sample
Percentage Median
diagnostic delay
in days (IQR)
*Adjusted
hazard ratio
95% conﬁdence
interval, p value
Bonferroni corrected
95% conﬁdence
interval, p value
Age (years) 16–25 324 23.8% 70 (20–308) 0.99 0.85–1.15,
p = 0.89
0.81–1.20, p = 1.0
26–35 404 29.6% 62 (16–214) Reference
36–45 277 20.3% 70 (23–327) 0.97 0.83–1.14,
p = 0.73
0.79–1.19, p = 1.0
46–55 150 11.0% 51 (14–166) 1.02 0.84–1.23,
p = 0.87
0.79–1.30, p = 1.0
56–65 89 6.5% 49 (13–390) 0.95 0.75–1.20,
p = 0.66
0.70–1.28, p = 1.0
Gender Female 734 53.8% 65 (16–267) Reference
Male 510 37.4% 64 (21–297) 1.01 0.90–1.13,
p = 0.87
0.90–1.13, p = 0.87
Ethnicity White 785 57.6% 68 (19–282) Reference
Asian 66 4.8% 70 (17–308) 0.2 0.55–0.94,
p = 0.02
0.51–1.00, p = 0.05
Black 232 17.0% 55 (13–301) 1.03 0.87–1.21,
p = 0.73
0.84–1.26, p = 1.0
Other 161 11.8% 56 (22–170) 1.07 0.90–1.27,
p = 0.42
0.87–1.32, p = 1.0
Marital
status
Married/Cohabiting 311 22.8% 50 (14–214) 1.1 0.96–1.27,
p = 0.19
0.93–1.31, p = 0.56
Divorced/Separated 117 8.6% 79 (22–420) 0.94 0.76–1.16,
p = 0.57
0.73–1.22, p = 1.0
Single 804 58.9% 67 (19–276) Reference
Widowed 12 0.9% 49 (12–140) 1.11 0.61–2.00,
p = 0.73
0.54–2.29, p = 1.0
UK Mental
Health Act
Compulsory admission
within 2 weeks of ﬁrst
presentation
216 15.8% 21 (6–79) 2.47 2.07–2.94,
p<0.001
2.07–2.94, p<0.001
Prior
Diagnoses
Schizophrenia or related
disorders
208 15.2% 214 (49–686) 0.4 0.34–0.48,
p<0.001
0.34–0.48, p<0.001
Psychotic depression 37 2.7% 370 (93–929) 0.73 0.52–1.04,
p = 0.08
0.52–1.04, p = 0.08
Unipolar depression
without psychotic
symptoms
133 9.8% 413 (128–1051) 0.4 0.33–0.48,
p<0.001
0.33–0.48, p<0.001
Anxiety disorder 78 5.7% 442 (158–901) 0.51 0.41–0.65,
p<0.001
0.41–0.65, p<0.001
Personality disorder 52 3.8% 494 (154–1025) 0.61 0.45–0.81,
p = 0.001
0.45–0.81, p = 0.001
Alcohol misuse or
dependence
26 1.9% 705 (389–1341) 0.45 0.30–0.68,
p<0.001
0.30–0.68, p<0.001
Illicit drug misuse or
dependence
36 2.6% 742 (320–1142) 0.43 0.31–0.61,
p<0.001
0.31–0.61, p<0.001
*Model adjusted for all factors listed in this table
doi:10.1371/journal.pone.0126530.t004
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diagnostic and treatment delay using records from primary healthcare services may help to elu-
cidate whether this is the case.
We established that there was no significant association of age, gender, ethnicity or marital
status with diagnostic or treatment delay. However, mode of presentation and previous diagno-
ses were associated with substantial differences in diagnostic and treatment delay. People who
underwent compulsory admission to hospital under the UK Mental Health Act had a shorter
delay to diagnosis and treatment. The reduced delay within this group may be explained by in-
creased severity of illness at presentation which necessitates prompt treatment and facilitates
diagnosis. However, it is possible this group may have experienced underlying symptoms of bi-
polar disorder for some time prior to presentation to specialist mental healthcare services.
Greater delays to diagnosis were seen among individuals with other psychiatric diagnoses
recorded prior to bipolar disorder. The greatest delays were associated with prior diagnoses of
alcohol or substance misuse disorders. This may reflect misattribution of symptoms of under-
lying bipolar disorder to an existing diagnostic framework rather than considering an alterna-
tive diagnosis. Furthermore, previous research suggests that people with symptoms of mania,
Fig 2. Kaplan-Meier plot of treatment delay.
doi:10.1371/journal.pone.0126530.g002
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Table 5. Factors associated with bipolar disorder treatment delay (n = 1247)*.
Factor Group Number in
sample
Percentage Median
treatment delay
in days (IQR)
**Adjusted
hazard ratio
95% conﬁdence
interval, p value
Bonferroni corrected
95% conﬁdence
interval, p value
Age (years) 16–25 314 25.2% 67 (7–532) 0.90 0.76–1.06,
p = 0.21
0.73–1.11, p = 0.85
26–35 408 32.7% 46 (9–260) Reference
36–45 288 23.1% 58 (15–369) 0.96 0.81–1.13,
p = 0.59
0.77–1.18, p = 1.0
46–55 150 12.0% 59 (12–318) 1.06 0.87–1.30,
p = 0.57
0.82–1.38, p = 1.0
56–65 87 7.0% 69 (19–367) 0.81 0.62–1.05,
p = 0.11
0.58–1.13, p = 0.43
Gender Female 720 57.7% 57 (11–369) Reference
Male 527 42.3% 51 (10–366) 1.09 0.96–1.23,
p = 0.19
0.96–1.23, p = 0.19
Ethnicity White 776 62.2% 73 (15–454) Reference
Asian 55 4.4% 20 (3–50) 1.44 1.08–1.93,
p = 0.01
1.00–2.08, p = 0.05
Black 208 16.7% 16 (3–147) 1.14 0.96–1.36,
p = 0.14
0.91–1.42, p = 0.55
Other 163 13.1% 56 (14–241) 0.97 0.81–1.17,
p = 0.78
0.77–1.23, p = 1.0
Ethnicity not recorded 45 3.6% 83 (38-)*** 0.68 0.48–0.98,
p = 0.04
0.43–1.08, p = 0.16
Marital
status
Married/Cohabiting 288 23.1% 38 (8–206) 1.05 0.90–1.23,
p = 0.52
0.86–1.28, p = 1.0
Divorced/Separated 113 9.1% 55 (11–369) 1.18 0.95–1.48,
p = 0.13
0.89–1.57, p = 0.54
Single 757 60.7% 67 (10–434) Reference
Widowed 11 0.9% 73 (13–826) 0.42 0.21–0.84,
p = 0.01
0.17–1.02, p = 0.06
Marital status not
recorded
78 6.3% 54 (14–1039) 0.89 0.67–1.17,
p = 0.40
0.63–1.26, p = 1.0
UK Mental
Health Act
Compulsory admission
within 2 weeks of ﬁrst
presentation
186 14.9% 3 (1–8) 4.40 3.64–5.32,
p<0.001
3.64–5.32, p<0.001
Prior
Diagnoses
Schizophrenia or related
disorders
183 14.7% 9 (3–75) 1.39 1.17–1.66,
p<0.001
1.17–1.66, p<0.001
Psychotic depression 35 2.8% 17 (4–109) 1.69 1.18–2.43,
p = 0.004
1.18–2.43, p = 0.004
Unipolar depression
without psychotic
symptoms
136 10.9% 237 (35–925) 0.75 0.61–0.92,
p = 0.005
0.61–0.92, p = 0.005
Anxiety disorder 81 6.5% 238 (24–792) 0.72 0.56–0.92,
p = 0.009
0.56–0.92, p = 0.009
Personality disorder 50 4.0% 179 (29–807) 0.92 0.67–1.26,
p = 0.61
0.67–1.26, p = 0.61
Alcohol misuse or
dependence
26 2.1% 705 (231–1221) 0.59 0.38–0.90,
p = 0.02
0.38–0.90, p = 0.02
Illicit drug misuse or
dependence
33 2.6% 352 (11–1104) 0.80 0.55–1.17,
p = 0.24
0.55–1.17, p = 0.24
*117 cases dropped in Cox regression analysis with treatment delay of 0 days
**Model adjusted for all factors listed in this table
***75% percentile inestimable due to right censoring
doi:10.1371/journal.pone.0126530.t005
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hypomania or depression are at increased risk of developing alcohol and substance misuse dis-
orders after initial onset of these symptoms[30,31]. These findings warrant increased awareness
of the possibility of dual diagnosis of a substance misuse disorder and bipolar disorder among
clinicians who see people at risk of these disorders[32]. While current UK treatment guidelines
highlight the need for prompt recognition and treatment of both substance misuse[33] and bi-
polar disorder[27], there is a clear need for further research in order to better understand and
treat comorbidity between the two disorders[34].
Our data also indicate a marked diagnostic delay in people who present with a prior history
of unipolar depression or anxiety. It is possible that a true diagnosis of bipolar disorder is diffi-
cult to elicit in such people if they have no clear history of symptoms of mania or hypomania
[35]. Delays to treatment were noted in people with other prior psychiatric diagnoses with the
exception of schizophrenia and psychotic depression. This could be explained by the use of sec-
ond generation antipsychotics to treat these disorders (which are also indicated in the treat-
ment of bipolar disorder) and indicates that misattribution of bipolar disorder symptoms to
another psychotic disorder may not significantly delay access to appropriate therapy even if di-
agnosis of bipolar disorder is delayed. Taken together, these findings indicate a need to be
aware of bipolar disorder in the differential diagnosis of individuals with other psychiatric dis-
orders, particularly among those with drug and alcohol misuse who may be using these sub-
stances secondary to experiencing affective or psychotic symptoms due to underlying bipolar
disorder[18,30].
Table 6. Test of proportionality of hazards on Schoenfeld residuals for treatment delay.
Factor Group Rho χ2 P value
Age (years) 16–25 0.02 0.5 0.48
26–35 Reference
36–45 0.07 4.9 0.03
46–55 0.05 3.0 0.08
56–65 0.06 4.5 0.03
Gender Female Reference
Male 0.02 0.5 0.48
Ethnicity White Reference
Asian -0.02 0.4 0.52
Black -0.02 0.3 0.59
Other 0.01 0.1 0.83
Ethnicity not recorded -0.01 0.0 0.84
Marital status Married/Cohabiting -0.03 1.11 0.30
Divorced/Separated 0.01 0.2 0.65
Single Reference
Widowed -0.02 0.6 0.44
Marital status not recorded -0.07 5.4 0.02
UK Mental Health Act Compulsory admission within 2 weeks of ﬁrst presentation -0.13 17.4 <0.001
Prior Diagnoses Schizophrenia or related disorders -0.01 0.1 0.83
Psychotic depression -0.01 0.1 0.73
Unipolar depression without psychotic symptoms 0.10 10.8 0.001
Anxiety disorder 0.08 6.6 0.01
Personality disorder 0.05 2.3 0.13
Alcohol misuse or dependence 0.05 2.4 0.12
Illicit drug misuse or dependence 0.02 0.5 0.50
doi:10.1371/journal.pone.0126530.t006
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Table 7. Factors associated with bipolar disorder treatment delay only including participants with complete covariate data (n = 1140)*.
Factor Group Number in
sample
Percentage Median
treatment delay
in days (IQR)
**Adjusted
hazard ratio
95% conﬁdence
interval, p value
Bonferroni corrected
95% conﬁdence
interval, p value
Age (years) 16–25 287 21.0% 51 (6–403) 0.96 0.81–1.14,
p = 0.66
0.77–1.20, p = 1.0
26–35 373 27.3% 49 (9–312) Reference
36–45 255 18.7% 55 (15–356) 0.99 0.83–1.18,
p = 0.92
0.79–1.24, p = 1.0
46–55 143 10.5% 59 (12–240) 1.1 0.90–1.36,
p = 0.36
0.85–1.44, p = 1.0
56–65 82 6.0% 68 (19–367) 0.8 0.61–1.05,
p = 0.11
0.53–1.13, p = 0.43
Gender Female 665 48.8% 56 (11–357) Reference
Male 475 34.8% 50 (8–341) 1.09 0.96–1.24,
p = 0.17
0.96–1.24, p = 0.17
Ethnicity White 731 53.6% 73 (16–434) Reference
Asian 52 3.8% 19 (3–50) 1.43 1.07–1.93,
p = 0.02
1.00–2.06, p = 0.05
Black 202 14.8% 16 (3–151) 1.13 0.94–1.35,
p = 0.18
0.91–1.40, p = 0.55
Other 155 11.4% 56 (14–260) 0.96 0.79–1.16,
p = 0.65
0.76–1.21, p = 1.0
Marital
status
Married/Cohabiting 281 20.6% 38 (8–212) 1.05 0.90–1.23,
p = 0.54
0.87–1.28, p = 1.0
Divorced/Separated 110 8.1% 53 (11–369) 1.21 0.97–1.52,
p = 0.09
0.92–1.59, p = 0.28
Single 738 54.1% 65 (10–403) Reference
Widowed 11 0.8% 13 (73–826) 0.42 0.21–0.84,
p = 0.02
0.18–0.98, p = 0.04
UK Mental
Health Act
Compulsory admission
within 2 weeks of ﬁrst
presentation
175 12.8% 4 (1–8) 4.26 3.50–5.19,
p<0.001
3.50–5.19, p<0.001
Prior
Diagnoses
Schizophrenia or related
disorders
180 13.2% 9 (3–68) 0.42 1.19–1.70,
p<0.001
1.19–1.70, p<0.001
Psychotic depression 35 2.6% 17 (4–109) 1.71 1.19–2.45,
p = 0.003
1.19–2.45, p = 0.003
Unipolar depression
without psychotic
symptoms
131 9.6% 218 (35–876) 0.75 0.61–0.92,
p = 0.006
0.61–0.92, p = 0.006
Anxiety disorder 77 5.6% 238 (24–792) 0.68 0.53–0.88,
p = 0.003
0.53–0.88, p = 0.003
Personality disorder 48 3.5% 169 (26–709) 0.93 0.68–1.28,
p = 0.66
0.68–1.28, p = 0.66
Alcohol misuse or
dependence
25 1.8% 832 (304–1221) 0.54 0.35–0.84,
p = 0.006
0.35–0.84, p = 0.006
Illicit drug misuse or
dependence
33 2.4% 352 (11–1104) 0.78 0.54–1.14,
p = 0.21
0.54–1.14, p = 0.21
*117 cases dropped in Cox regression analysis with treatment delay of 0 days
**Model adjusted for all factors listed in this table
doi:10.1371/journal.pone.0126530.t007
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Strengths and Limitations
The generalisability of our findings is strengthened because they were derived from routinely
recorded clinical information that is representative of a population served by a large centre for
mental healthcare. Furthermore, the data analysed in our study were recorded prospectively,
thereby reducing the risk of information and recall bias. Although there were some missing
data for covariates (ethnicity and marital status), sensitivity analyses including only partici-
pants with complete covariate data did not yield any meaningful differences in outcomes. Tests
of proportionality of hazards did reveal skewed distribution of diagnostic delay and treatment
delay for certain predictor variables. It is therefore not possible to make comparative inferences
based on the relative magnitude of hazard ratios between predictor variables. However, it is
still possible to draw the conclusions described previously based on differences in the direction
of hazard between predictor variables. Furthermore, multiple linear regression revealed compa-
rable results to Cox regression in the analysis of diagnostic delay.
Our study is also limited by virtue of analysing routinely recorded clinical data from second-
ary mental healthcare records. It was only possible to investigate factors associated with diag-
nostic and treatment delay from the point of receiving specialist mental healthcare in the
centre investigated in our study. However, some individuals within the catchment area of the
study centre may have initially presented to other healthcare services. It is therefore possible
that the associations on subsequent delay reported in our study would be applicable to delays
while receiving non-specialist healthcare. Further study examining clinical records from pri-
mary healthcare would help to elucidate this. Although 75% of people included in our study
had been diagnosed within one year of follow-up, the follow-up period of 2007 to 2012 may
not have been long enough to identify people with even longer delays to bipolar disorder diag-
nosis. While it was possible to obtain data on a range of demographic and diagnostic variables,
it was not possible to obtain detailed diagnostic and symptom data using clinical rating scales
such as the SCAN[36] or YMRS[37]. Previous studies have indicated that factors such as em-
ployment status[38], social support[39], deliberate self-harm[40] and the clinical experience of
clinicians who first assess patients may play a role in determining delays to diagnosis and treat-
ment. Although it was possible to analyse data on age, gender, ethnicity and marital status in
our study, it was not possible to obtain data on other factors from routinely recorded electronic
health records.
Conclusion
In summary, our study indicates that certain individuals experience a significant delay in diag-
nosis and treatment of bipolar disorder after initiation of specialist mental healthcare, particu-
larly those who have prior diagnoses of alcohol and substance misuse disorders. These findings
highlight a need for further study on strategies to better identify underlying symptoms and
offer appropriate treatment sooner in order to facilitate improved clinical outcomes, such as
developing specialist early intervention services to identify and treat people with bipolar
disorder.
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